<p>Profound Medical Corp. (TSE:PRN - 獲取免費報告) 的股價在週二的午盤交易中達到了新的 52 周高點。該股最高交易價為 C$12.40，最後交易價為 C$11.85，成交量為 11025 股。該股此前收盤價為 C$12.11。</p>
<p>獲取 <strong>Profound Medical</strong> 的提醒：</p>
<h2>Profound Medical 股票表現</h2>
<p>該公司的債務與股本比率為 20.05，速動比率為 14.98，流動比率為 6.12。公司的市值為 4.21 億加元，市盈率為-8.79，貝塔值為 1.19。該業務的 50 日移動平均線為 C$9.67，200 日移動平均線為 C$8.15。</p>
<p>Profound Medical (TSE:PRN - 獲取免費報告) 最近在 11 月 13 日（星期四）發佈了其財報。該公司報告本季度每股收益為 C$0.26。Profound Medical 的股本回報率為-85.22%，淨利潤率為-349.41%。該業務在本季度的收入為 736 萬加元。賣方分析師平均預測 Profound Medical Corp. 在當前財政年度將發佈-1.9000001 的每股收益。</p>
<h2>Profound Medical 公司簡介</h2>
<p>(獲取免費報告)</p>
<p>Profound Medical Corp. 及其子公司作為一家商業階段的醫療設備公司，開發和銷售無切口的治療系統，用於在加拿大、德國、美國和芬蘭進行影像引導的病變組織消融。其主打產品 TULSA-PRO 系統結合了磁共振成像（MRI）、機器人驅動的經尿道清掃動作/熱超聲和閉環温度反饋控制，以提供外科醫生定義區域的精確、靈活和持久的消融，並保護尿道和直腸。</p>
<h2>進一步閲讀</h2>
<ul>
<li>我們更看好的五隻股票比 Profound Medical 更好</li>
<li>Elon 將 SpaceX 上市！$100 的首次公開募股機會！</li>
<li>家族信託如何幫助保護您的財富</li>
<li>一項價值數萬億的美國 “出生權” 索賠 - 靜悄悄地激活</li>
<li>這隻股票獲得 94 分（滿分 100 分）</li>
<li>自 2007 年以來首次：所有警告均已激活</li>
</ul>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>您現在應該投資$1,000 在 Profound Medical 嗎？</h2>
<p>在您考慮 Profound Medical 之前，您需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Profound Medical 並不在名單上。</p>
<p>雖然 Profound Medical 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

PROF

<p>Profound Medical（多倫多證券交易所代碼：PRN）在交易中達到了新的 52 周高點 C$12.40，收盤價為 C$11.85。該公司的市值為 C$4.21 億，市盈率為-8.79，報告的收入為 C$736 萬，預計本財年的每股收益為-1.90。分析師目前對該股票的評級為持有，建議可能有更好的投資選擇</p>

<p>Profound Medical Corp. (TSE:PRN - Get Free Report)'s stock price reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as C$12.40 and last traded at C$11.85, with a volume of 11025 shares traded. The stock had previously closed at C$12.11.</p>
<div class="lb-trans"><p>Profound Medical Corp. (TSE:PRN - 獲取免費報告) 的股價在週二的午盤交易中達到了新的 52 周高點。該股最高交易價為 C$12.40，最後交易價為 C$11.85，成交量為 11025 股。該股此前收盤價為 C$12.11。</p>
</div><p>Get <strong>Profound Medical</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Profound Medical</strong> 的提醒：</p>
</div><h2>Profound Medical Stock Performance</h2>
<div class="lb-trans"><h2>Profound Medical 股票表現</h2>
</div><p>The company has a debt-to-equity ratio of 20.05, a quick ratio of 14.98 and a current ratio of 6.12. The company has a market capitalization of C$421.00 million, a P/E ratio of -8.79 and a beta of 1.19. The business has a 50 day moving average of C$9.67 and a 200-day moving average of C$8.15.</p>
<div class="lb-trans"><p>該公司的債務與股本比率為 20.05，速動比率為 14.98，流動比率為 6.12。公司的市值為 4.21 億加元，市盈率為-8.79，貝塔值為 1.19。該業務的 50 日移動平均線為 C$9.67，200 日移動平均線為 C$8.15。</p>
</div><p>Profound Medical (TSE:PRN - Get Free Report) last issued its earnings results on Thursday, November 13th. The company reported C$0.26 EPS for the quarter. Profound Medical had a negative return on equity of 85.22% and a negative net margin of 349.41%.The business had revenue of C$7.36 million during the quarter. On average, sell-side analysts predict that Profound Medical Corp. will post -1.9000001 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Profound Medical (TSE:PRN - 獲取免費報告) 最近在 11 月 13 日（星期四）發佈了其財報。該公司報告本季度每股收益為 C$0.26。Profound Medical 的股本回報率為-85.22%，淨利潤率為-349.41%。該業務在本季度的收入為 736 萬加元。賣方分析師平均預測 Profound Medical Corp. 在當前財政年度將發佈-1.9000001 的每股收益。</p>
</div><h2>Profound Medical Company Profile</h2>
<div class="lb-trans"><h2>Profound Medical 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><p>Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.</p>
<div class="lb-trans"><p>Profound Medical Corp. 及其子公司作為一家商業階段的醫療設備公司，開發和銷售無切口的治療系統，用於在加拿大、德國、美國和芬蘭進行影像引導的病變組織消融。其主打產品 TULSA-PRO 系統結合了磁共振成像（MRI）、機器人驅動的經尿道清掃動作/熱超聲和閉環温度反饋控制，以提供外科醫生定義區域的精確、靈活和持久的消融，並保護尿道和直腸。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Profound Medical</li>
<li>Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!</li>
<li>How a Family Trust May Be Able To Help Preserve Your Wealth</li>
<li>A U.S. “birthright” claim worth trillions - activated quietly</li>
<li>This stock gets a 94 out of 100</li>
<li>First Time Since 2007: All Warnings Active</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比 Profound Medical 更好</li>
<li>Elon 將 SpaceX 上市！$100 的首次公開募股機會！</li>
<li>家族信託如何幫助保護您的財富</li>
<li>一項價值數萬億的美國 “出生權” 索賠 - 靜悄悄地激活</li>
<li>這隻股票獲得 94 分（滿分 100 分）</li>
<li>自 2007 年以來首次：所有警告均已激活</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Profound Medical Right Now?</h2>
<div class="lb-trans"><h2>您現在應該投資$1,000 在 Profound Medical 嗎？</h2>
</div><p>Before you consider Profound Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考慮 Profound Medical 之前，您需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Profound Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Profound Medical 並不在名單上。</p>
</div><p>While Profound Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Profound Medical 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Profound Medical（TSE:PRN）創下 1 年新高 - 現在是買入的好時機嗎？